(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -3.45%13.35B | -2.08%10.03B | 8.20%6.92B | 7.16%3.2B | 45.03%13.83B | 50.88%10.24B | 46.87%6.39B | 55.95%2.98B | 15.99%9.54B | 24.73%6.79B |
Operating income | -3.45%13.35B | -2.08%10.03B | 8.20%6.92B | 7.16%3.2B | 45.03%13.83B | 50.88%10.24B | 46.87%6.39B | 55.95%2.98B | 15.99%9.54B | 24.73%6.79B |
Operating expenses | 4.78%-10.08B | 5.61%-7.42B | -3.13%-5.11B | -0.41%-2.38B | -38.14%-10.59B | -44.78%-7.86B | -42.99%-4.96B | -55.00%-2.37B | -16.59%-7.66B | -32.92%-5.43B |
Gross profit | 0.89%3.27B | 9.59%2.61B | 25.69%1.8B | 33.45%813.07M | 73.26%3.24B | 75.31%2.38B | 62.06%1.44B | 59.77%609.28M | 13.58%1.87B | 0.04%1.36B |
Selling expenses | -21.45%-502.29M | -27.89%-347.72M | -33.24%-229.45M | -30.89%-110.94M | -53.27%-413.58M | -40.24%-271.89M | -40.44%-172.21M | -70.69%-84.75M | -16.65%-269.83M | 16.45%-193.88M |
Administrative expenses | -34.58%-1.05B | -38.06%-738.38M | -55.99%-479.44M | -50.51%-227.11M | -25.40%-778.8M | -26.74%-534.81M | -7.82%-307.35M | -22.50%-150.89M | -30.41%-621.06M | -39.27%-421.97M |
Research and development expenses | 1.13%-774.99M | -2.62%-558.71M | -14.87%-367.56M | -30.10%-181.21M | -65.67%-783.89M | -70.08%-544.43M | -59.37%-319.98M | -70.64%-139.29M | -14.13%-473.16M | -21.09%-320.11M |
Profit from asset sales | 7.15%-2.22M | 267.60%2.42M | 15.39%-1.12M | 174.03%490.01K | -597.10%-2.4M | -87.79%-1.44M | -152.30%-1.33M | -2,051.53%-661.87K | -119.54%-343.63K | -130.72%-768.48K |
Revaluation surplus | 13.70%10.77M | 849.56%5.9M | 377.09%4.83M | 231.58%2.64M | -97.21%9.47M | -100.25%-787.06K | -100.54%-1.74M | 160.43%795.3K | 260.14%339.08M | 297,965.66%320.76M |
-Changes in the fair value of other assets | 13.70%10.77M | 849.56%5.9M | 377.09%4.83M | 231.58%2.64M | -97.21%9.47M | -100.25%-787.06K | -100.54%-1.74M | 160.43%795.3K | 260.14%339.08M | 297,965.66%320.76M |
Impairment and provision | -16.67%-237.85M | -50.53%-154.85M | -101.27%-148.49M | 5.48%-36.38M | -30.17%-203.87M | 20.97%-102.87M | 30.35%-73.78M | 14.60%-38.49M | -28.45%-156.62M | -47.10%-130.17M |
-Other impairment is provision | -16.67%-237.85M | -50.53%-154.85M | -101.27%-148.49M | 5.48%-36.38M | -30.17%-203.87M | 20.97%-102.87M | 30.35%-73.78M | 14.60%-38.49M | -28.45%-156.62M | -47.10%-130.17M |
Special items of operating profit | 168.47%723.01M | 128.88%257.69M | 160.03%181.24M | -34.01%34.48M | 46.20%269.31M | 20.93%112.59M | 12.68%69.7M | 43.62%52.26M | 12.39%184.21M | 103.95%93.11M |
Operating profit | 7.42%1.35B | 1.91%992.79M | 19.03%706.87M | 19.34%279.07M | 48.98%1.25B | 43.66%974.21M | 10.77%593.85M | 107.35%233.85M | 31.11%841.12M | 34.65%678.12M |
Financing cost | -53.63%-127.33M | -67.63%-101.18M | 39.58%-21.77M | -150.14%-33.21M | 32.50%-82.88M | 32.98%-60.36M | 23.42%-36.03M | 38.54%-13.28M | -101.71%-122.79M | -30.67%-90.06M |
Special items of earning before tax | 87.38%-2.31M | 468.15%820.4K | -419.18%-4.07M | -492.24%-2.46M | -161.60%-18.28M | -100.77%-222.84K | -95.36%1.28M | 149.16%627.26K | 2,204.15%29.67M | 1,978.53%28.8M |
Earning before tax | 5.60%1.22B | -2.32%892.43M | 21.81%681.03M | 10.04%243.4M | 54.01%1.15B | 48.11%913.63M | 8.24%559.09M | 146.06%221.2M | 29.13%748M | 41.45%616.86M |
Tax | -525.93%-39.49M | -34.85%-67.16M | -31.13%-54.67M | -115.28%-23.28M | 133.93%9.27M | -22.89%-49.8M | -35.53%-41.7M | -285.14%-10.82M | 22.02%-27.33M | -34.37%-40.53M |
After-tax profit from continuing operations | 1.35%1.18B | -4.46%825.27M | 21.06%626.36M | 4.63%220.12M | 61.13%1.16B | 49.88%863.83M | 6.51%517.4M | 141.57%210.38M | 32.43%720.68M | 41.98%576.34M |
Earning after tax | 1.35%1.18B | -4.46%825.27M | 21.06%626.36M | 4.63%220.12M | 61.13%1.16B | 49.88%863.83M | 6.51%517.4M | 141.57%210.38M | 32.43%720.68M | 41.98%576.34M |
Minority profit | -1,993.09%-120.5M | -376.99%-55.32M | 341.96%19.35M | -407.44%-20.92M | -147.31%-5.76M | -195.21%-11.6M | -221.20%-8M | 159.13%6.8M | 2,230.53%12.17M | 54,967.18%12.18M |
Profit attributable to shareholders | 11.18%1.3B | 0.59%880.59M | 15.54%607.01M | 18.40%241.04M | 64.71%1.17B | 55.17%875.42M | 9.65%525.39M | 141.03%203.58M | 30.32%708.51M | 38.98%564.15M |
Basic earnings per share | 11.04%1.71 | 0.00%1.16 | 15.94%0.8 | 18.52%0.32 | 63.83%1.54 | 54.67%1.16 | 9.52%0.69 | 145.45%0.27 | 30.56%0.94 | 38.89%0.75 |
Diluted earnings per share | 11.04%1.71 | 0.00%1.16 | 15.94%0.8 | 18.52%0.32 | 63.83%1.54 | 56.76%1.16 | 9.52%0.69 | 145.45%0.27 | 30.56%0.94 | 37.04%0.74 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data